Freelance science journalist, covering drugs, clinical trials, biotech, pharma and more. Writes for Nature, The Lancet, The New Scientist, and others.

Search Tweets

Twitter Feed

@AsherMullard — 624 followers, 233 tweets

Nov 16, 2017

FDA approved emicizumab for hemophilia A, a first green light for a non-oncology bispecific antibody. ~20 more in the pipeline, but innovation needed, shows recent @NatRevDrugDisc article https://t.co/7pBFM0PVHP

Oct 30, 2017

RT @NatRevDrugDisc: Nora Volkow, director of the US National Institute on Drug Abuse, discusses plans to help address the #OpioidCrisis

Show More